A First-in-Human Phase 1a/1b Study to Evaluate Safety and Tolerability of QXL138AM in Patients with Locally Advanced Un-Resectable and/or Metastatic Solid Tumors and Multiple Myeloma

Protocol No
NAMMI-QXL138AM-001
Staff Member
Binod Dhakal
Phase
I
Summary

This project is being done to research the safety and tolerability of a new investigational treatment, QXL138AM, in participants with advanced solid tumors and multiple myeloma.
Objective
Safety, PK and efficacy of QXL138AM in patients with solid tumors and multiple myeloma
Status
OPEN TO ACCRUAL
Categories
Cancer, Multiple Myeloma, Pancreas/Liver, Bladder, Breast Cancers, Kidney, Lung, Hematologic/Blood Related Cancers, Gastrointestinal Cancers, Thoracic Cancers, Prostate and Urologic Cancers
ClinicalTrials.gov
https://www.clinicaltrials.gov/study/NCT06582017